Which bodies have the power to regulate clinical trials?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which bodies have the power to regulate clinical trials?

Explanation:
Regulatory authorities are the formal bodies with the legal power to regulate clinical trials. They set and enforce the rules that govern trial design, conduct, participant protection, and data integrity, and they grant, suspend, or terminate permission to run a study. They require safety reporting, monitor compliance through inspections, and can mandate corrective actions or protocol changes as needed. Source documents and QA activities are parts of how trials are run and checked, and a protocol amendment is a change to the trial plan—the regulator may need to review or approve it, but the authority to regulate comes from Regulatory Authorities, not those other elements. Examples include the FDA in the United States and equivalent agencies worldwide.

Regulatory authorities are the formal bodies with the legal power to regulate clinical trials. They set and enforce the rules that govern trial design, conduct, participant protection, and data integrity, and they grant, suspend, or terminate permission to run a study. They require safety reporting, monitor compliance through inspections, and can mandate corrective actions or protocol changes as needed. Source documents and QA activities are parts of how trials are run and checked, and a protocol amendment is a change to the trial plan—the regulator may need to review or approve it, but the authority to regulate comes from Regulatory Authorities, not those other elements. Examples include the FDA in the United States and equivalent agencies worldwide.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy